Express Scripts, Inc. and Express Scripts Pharmacy Services, Inc. agreed to pay 2.75 million to settle the case against the companies. DEA Philadelphia Diversion Group 1 inspected company locations in Pennsylvania and discovered numerous instances of drug diversion and regulatory violations.